CAS NO: | 2756333-39-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | AZD-9574 is a potent and brain penetrantPARP1inhibitor and shows >8000-fold selectivity forPARP1compared to PARP2/3/5a/6. AZD-9574 acts by selectively inhibiting and trappingPARP1at the sites of SSBs. AZD-9574 is an anti-cancer agent and can be used for HRD+ breastcancerand advanced solid malignancies research[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | AZD-9574 inhibits PARP1 enzymatic activity with IC50s range between 0.3-2 nM in all tested cell lines irrespective of the homologous recombination repair (HRR) status[1].In isogenic cell lines pairs confirms higher potency and selectivity towards HRR-deficient (HRD+) models (DLD1 BRCA2-/-; SKOV-3 BRCA2-/- and SKOV-3 PALB2-/-). The IC50in BRCA2-/- DLD1 cells is 1.38 nM compared to IC50 >40 μM BRCA2wt cells[1]. | ||||||||||||||||
体内研究 (In Vivo) | AZD-9574 (3 mg/kg) shows sustained tumour growth suppression resulting in a significantly extended survival of tumour-bearing mice, in intracranial xenograft model of breast cancer brain metastases[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 428.44 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H22F2N6O2 | ||||||||||||||||
CAS 号 | 2756333-39-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 22.22 mg/mL(51.86 mM;ultrasonic and adjust pH to 4 with HCl) DMSO : 8.33 mg/mL(19.44 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|